Freshfields Bruckhaus Deringer (‘Freshfields’) advised Shanghai Henlius Biotech, Inc. on its proposed privatisation. Shanghai Henlius Biotech, Inc. (‘Henlius’), a biopharmaceutical company listed on the Hong Kong...
Shanghai Henlius Biotech’s Privatization by Fosun New Medicine
Zijin Mining Group’s US$2bn Bond Issuance and HK$3.9bn Share Placement
Freshfields advised Zijin Mining Group on multibillion dollar convertible bond issuance and share placement. Zijin Mining Group Co., Ltd. (‘Zijin Mining Group’) has undertaken two significant...
Marketingforce Management’s IPO on the Hong Kong Stock Exchange
Marketingforce Management’s IPO on the Hong Kong Stock Exchange. On May 16, 2024, Marketingforce Management Ltd, a prominent sales and marketing software-as-a-service (SaaS) solution provider in...
DPC Dash’s Listing on HKSE
Freshfields Bruckhaus Deringer advised Merrill Lynch (Asia Pacific) Limited. Merrill Lynch (Asia Pacific) Limited acted the sole sponsor in the global offering and listing of shares of...
Shanghai Chicmax Cosmetic Co., Ltd.’s US$141.5 Million Initial Public Offering on the HKSE
Clifford Chance and JunHe advised cosmetics company Shanghai Chicmax Cosmetic Co., Ltd. on the deal. Freshfields Bruckhaus Deringer advised the joint sponsors. Shanghai Chicmax Cosmetic Co.,...
Tencent Music Entertainment Group’s Secondary Listing on The HKSE
Slaughter and May, Maples and Calder, Davis Polk & Wardwell and Han Kun Law Offices advised Tencent Holdings Limited on the deal. Freshfields Bruckhaus Deringer and...
KE Holdings Inc. (Beike)’s Dual Primary Listing in Hong Kong
Harneys acted as Cayman Islands to Beike, Freshfields Bruckhaus Deringer as to Hong Kong law, Skadden, Arps, Slate, Meagher & Flom LLP as to US law...
XPeng Inc.’s US$1.8 Billion Shares Offering
Freshfields Bruckhaus Deringer advised a group of underwriters led by J.P. Morgan Securities (Asia Pacific) Limited and Merrill Lynch (Asia Pacific) Limited on the US SEC...